
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Global Safety Assessment of Adverse Events of Special Interest Following 2 Years of Use and 772 Million Administered Doses of mRNA-1273
Verónica Urdaneta, Daina B. Esposito, Priyadarshani Dharia, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 5
Verónica Urdaneta, Daina B. Esposito, Priyadarshani Dharia, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 3
Open Access | Times Cited: 5
Showing 5 citing articles:
Opportunities and challenges to implementing mRNA-based vaccines and medicines: lessons from COVID-19
Shehzad Iqbal, Andrew M. Rosen, Darin K. Edwards, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 7
Shehzad Iqbal, Andrew M. Rosen, Darin K. Edwards, et al.
Frontiers in Public Health (2024) Vol. 12
Open Access | Times Cited: 7
A review of the immunogenicity and safety of booster doses of omicron variant-containing mRNA-1273 COVID-19 vaccines in adults and children
Frances Priddy, Spyros Chalkias, Brandon Essink, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 862-878
Open Access | Times Cited: 4
Frances Priddy, Spyros Chalkias, Brandon Essink, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 862-878
Open Access | Times Cited: 4
COVID-19 Modified mRNA “Vaccines”: Lessons Learned from Clinical Trials, Mass Vaccination, and the Bio-Pharmaceutical Complex, Part 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
M. Nathaniel Mead, Stephanie Seneff, Jessica Rose, et al.
International Journal of Vaccine Theory Practice and Research (2024) Vol. 3, Iss. 2, pp. 1275-1344
Open Access | Times Cited: 2
A descriptive review on the real-world impact of Moderna, inc. COVID-19 vaccines
Mary T. Bausch-Jurken, Rachel Dawson, Francesca Ceddia, et al.
Expert Review of Vaccines (2024)
Open Access | Times Cited: 1
Mary T. Bausch-Jurken, Rachel Dawson, Francesca Ceddia, et al.
Expert Review of Vaccines (2024)
Open Access | Times Cited: 1
Association between Reactogenicity and Immunogenicity in a Vaccinated Cohort with Two mRNA SARS-CoV-2 Vaccines at a High-Complexity Reference Hospital: A Post Hoc Analysis on Immunology Aspects of a Prospective Cohort Study
Joaquín Sáez‐Peñataro, Gonzalo Calvo, Juan Bascuas, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 665-665
Open Access
Joaquín Sáez‐Peñataro, Gonzalo Calvo, Juan Bascuas, et al.
Vaccines (2024) Vol. 12, Iss. 6, pp. 665-665
Open Access